(Q42805286)

English

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.

scientific article published on November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2. (English)

1 reference

Europe PubMed Central

7 November 2017

0 references

10

object named as

Eric Stice

1 reference

Europe PubMed Central

7 November 2017

1

object named as

Kenneth Blum

1 reference

Europe PubMed Central

7 November 2017

Eric R. Braverman

16

object named as

Eric R Braverman

1 reference

Europe PubMed Central

7 November 2017

4

object named as

John Giordano

1 reference

Europe PubMed Central

7 November 2017

author name string

Thomas J H Chen

2

1 reference

Europe PubMed Central

7 November 2017

Siobhan Morse

3

1 reference

Europe PubMed Central

7 November 2017

Amanda Lih Chaun Chen

5

1 reference

Europe PubMed Central

7 November 2017

James Thompson

6

1 reference

Europe PubMed Central

7 November 2017

Cameron Allen

7

1 reference

Europe PubMed Central

7 November 2017

Andrew Smolen

8

1 reference

Europe PubMed Central

7 November 2017

Joel Lubar

9

1 reference

Europe PubMed Central

7 November 2017

B William Downs

11

1 reference

Europe PubMed Central

7 November 2017

Roger L Waite

12

1 reference

Europe PubMed Central

7 November 2017

Margaret A Madigan

13

1 reference

Europe PubMed Central

7 November 2017

Mallory Kerner

14

1 reference

Europe PubMed Central

7 November 2017

Frank Fornari

15

1 reference

Europe PubMed Central

7 November 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

7 November 2017

Postgraduate Medicine

1 reference

Europe PubMed Central

7 November 2017

122

1 reference

Europe PubMed Central

7 November 2017

6

1 reference

Europe PubMed Central

7 November 2017

214-226

1 reference

Europe PubMed Central

7 November 2017

Substance abuse in the United States: findings from recent epidemiologic studies

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Dissociation of "conscious desire" (craving) from and relapse in alcohol and cocaine dependence

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Quantitative electroencephalographic analyses in cocaine-preferring polysubstance abusers during abstinence.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Allelic association of the D2 dopamine receptor gene with cocaine dependence

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Genotyping of three single nucleotide polymorphisms following whole genome preamplification of DNA collected from buccal cells

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Multiple dopamine D4 receptor variants in the human population

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

A functional polymorphism in the monoamine oxidase A gene promoter

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Role of genotype in the cycle of violence in maltreated children

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

New concepts in cocaine addiction: the dopamine depletion hypothesis

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Genetic, personality, and environmental predictors of drug use in adolescents

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

The human cerebral cortex: gender differences in structure and function.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2237

21 January 2018

Identifiers

10.3810/PGM.2010.11.2237

1 reference

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42805286&oldid=1582533233"